基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
Epidemiological evidence suggests that patients with hypertension infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are at increased risk of acute lung injury. However, it is still not clear whether this increased risk is related to the usage of renin-angiotensin system (RAS) blockers. We collected medical records of coronavirus disease 2019 (COVID-19) patients from the First Affiliated Hospital, Zhejiang University School of Medicine (Hangzhou, China), and evaluated the potential impact of an angiotensin Ⅱ receptor blocker (ARB) on the clinical outcomes of COVID-19 patients with hypertension. A total of 30 hypertensive COVID-19 patients were enrolled, of which 17 were classified as non-ARB group and the remaining 13 as ARB group based on the antihypertensive therapies they received. Compared with the non-ARB group, patients in the ARB group had a lower proportion of severe cases and intensive care unit (ICU) admission as well as shortened length of hospital stay, and manifested favorable results in most of the laboratory testing. Viral loads in the ARB group were lower than those in the non-ARB group throughout the disease course. No significant difference in the time of seroconversion or antibody levels was observed between the two groups. The median levels of soluble angiotensin-converting enzyme 2 (sACE2) in serum and urine samples were similar in both groups, and there were no significant correlations between serum sACE2 and biomarkers of disease severity. Transcriptional analysis showed 125 differentially expressed genes which mainly were enriched in oxygen transport, bicarbonate transport, and blood coagulation. Our results suggest that ARB usage is not associated with aggravation of COVID-19. These findings support the maintenance of ARB treatment in hypertensive patients diagnosed with COVID-19.
推荐文章
COVID-19临床资料分析
新型冠状病毒
感染
新型冠状病毒性肺炎
COVID-19疫情下方舱CT的紧急建设
新型冠状病毒肺炎
方舱CT
辐射防护
CT质量控制
儿童COVID-19的流行病学与临床诊疗特点
新型冠状病毒肺炎
儿童
流行病学
诊断治疗
COVID-19合并肺血栓栓塞症的临床特点
新型冠状病毒肺炎
新型冠状病毒
肺栓塞
预后
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Effects of angiotensin Ⅱ receptor blocker usage on viral load, antibody dynamics, and transcriptional characteristics among COVID-19 patients with hypertension
来源期刊 浙江大学学报(英文版)(B辑:生物医学和生物技术) 学科
关键词
年,卷(期) 2021,(4) 所属期刊栏目 Research Articles
研究方向 页码范围 330-340,后插1-后插4
页数 1页 分类号
字数 语种 英文
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (14)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2005(2)
  • 参考文献(2)
  • 二级参考文献(0)
2017(1)
  • 参考文献(1)
  • 二级参考文献(0)
2020(11)
  • 参考文献(11)
  • 二级参考文献(0)
2021(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
引文网络交叉学科
相关学者/机构
期刊影响力
浙江大学学报(英文版)(B辑:生物医学和生物技术)
月刊
1673-1581
33-1356/Q
杭州玉古路20号
eng
出版文献量(篇)
2221
总下载数(次)
1
  • 期刊分类
  • 期刊(年)
  • 期刊(期)
  • 期刊推荐
论文1v1指导